Health knowledge made personal
Join this community!
› Share page:
Go
Search posts:

Update:Unknown bacteria found in Tylenol,Benadryl,McNeil products

Posted May 06 2010 12:50pm

Now the FDA is reporting that the allergy and cold medicines recalled last week are contaminated with an unknown bacteria...yet they are saying it is not known to be harmful. Yet their have been over 46 consumer complaints regarding the unknown bacteria. I thought last week they said it was being recalled due to improper mixture of ingredients? Now it is because of an unknown bacteria? According to the latest report,the FDA did an inspection in mid-April;siting numerous deficiencies yet the recall was supposedly voluntary by McNeil Health last week? Did the FDA withhold important consumer information before the company decided to issue their own recall?

At this time you are advised to throw out any of the effected medicines and purchase generic equivalents;if you are not sure check with your doctor or pharmacist.

McNeil Consumer Healthcare product recalls.

Click here for press release.

Click here to request a refund or high value coupon.

McNeil Consumer Healthcare product recalls.

Click here for press release.

Click here to request a refund or high value coupon.

For more information on the recall, head to a special "What Consumers Need to Know" page at the U.S. Food and Drug Administration .

TUESDAY, May 4 (HealthDay News) -- Bacterial contamination has been found in ingredients used to make the liquid cold and allergy products for children that were recalled Friday by drug giant McNeil Consumer Healthcare, according to a report issued late Tuesday by the U.S. Food and Drug Administration.

Last Friday, McNeil initiated a voluntary recall of more than 40 products, including liquid Tylenol, Tylenol Plus, Motrin, Zyrtec and Benadryl. These medications have been sold in the United States and 11 other countries. In all, about 1,500 lots of these products have been recalled.

The company also closed its plant in Fort Washington, Pa., where the contaminated products were made. The plant remains closed and cannot reopen without FDA approval.

Speaking at a Tuesday afternoon press briefing, Deborah M. Autor, director of the FDA's Office of Compliance, Center for Drug Evaluation and Research, said that in February, the agency met with executives of McNeil Healthcare and its corporate parent Johnson & Johnson to complain about the company's manufacturing practices.

McNeil had received 46 consumer complaints of foreign substances in its products, the FDA said.

Read More








 


   

Post a comment
Write a comment:

Related Searches